Treatments of nonalcoholic fatty liver disease in adults who have no other illness : A Review article
Copyright © 2019 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved..
Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases. In the absence of treatment, NAFLD can damage the liver tissue and even have extra-hepatic complications. No therapeutic regimen has ever been approved for the treatment of this disease. A variety of clinical trials have been conducted in the field of NAFLD. Reviewing these trials is necessary to provide the most effective treatments. In this article, we aimed to review randomized controlled trials that evaluate the effects of pharmacological agents on NAFLD adults without other illness.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology - 20(2019), 4 vom: 15. Dez., Seite 189-197 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ahadi, Sepideh [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adults |
|---|
| Anmerkungen: |
Date Completed 11.05.2020 Date Revised 11.05.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ajg.2019.11.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM304080691 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM304080691 | ||
| 003 | DE-627 | ||
| 005 | 20231225114218.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajg.2019.11.004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1013.xml |
| 035 | |a (DE-627)NLM304080691 | ||
| 035 | |a (NLM)31806408 | ||
| 035 | |a (PII)S1687-1979(19)30100-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ahadi, Sepideh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatments of nonalcoholic fatty liver disease in adults who have no other illness |b A Review article |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.05.2020 | ||
| 500 | |a Date Revised 11.05.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2019 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases. In the absence of treatment, NAFLD can damage the liver tissue and even have extra-hepatic complications. No therapeutic regimen has ever been approved for the treatment of this disease. A variety of clinical trials have been conducted in the field of NAFLD. Reviewing these trials is necessary to provide the most effective treatments. In this article, we aimed to review randomized controlled trials that evaluate the effects of pharmacological agents on NAFLD adults without other illness | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Adults | |
| 650 | 4 | |a Nonalcoholic fatty liver | |
| 650 | 4 | |a Pharmacotherapy | |
| 650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
| 650 | 7 | |a Lipid Regulating Agents |2 NLM | |
| 700 | 1 | |a Gharekhani, Afshin |e verfasserin |4 aut | |
| 700 | 1 | |a Shiva, Afshin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology |d 2009 |g 20(2019), 4 vom: 15. Dez., Seite 189-197 |w (DE-627)NLM206874979 |x 2090-2387 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2019 |g number:4 |g day:15 |g month:12 |g pages:189-197 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ajg.2019.11.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2019 |e 4 |b 15 |c 12 |h 189-197 | ||